As of 2026-10-16, the EV/EBITDA ratio of Intercept Pharmaceuticals Inc (ICPT) is -22.57. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ICPT's latest enterprise value is 915.51 mil USD. ICPT's TTM EBITDA according to its financial statements is -40.56 mil USD. Dividing these 2 quantities gives us the above ICPT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.0x - 15.3x | 13.0x |
| Forward P/E multiples | 11.8x - 17.7x | 14.6x |
| Fair Price | (14.38) - (17.74) | (16.28) |
| Upside | -175.7% - -193.4% | -185.7% |
| Date | EV/EBITDA |